No Data
No Data
No Data
No Data
No Data
Lobe Sciences Ltd. Announces That The Drug Enforcement Administration Has Issued The Initial 2023 Quota Allowing Export Of L-130
Yahoo FinanceMar 22, 2023 09:08 ET
Lobe Sciences Ltd. Announces Exclusive Collaboration With Quality Chemical Laboratories LLC
Quality Chemical Laboratories LLC ("QCL") has developed a synthetic pathway for psilocybin, psilocin and psilocin analogues exclusively for Lobe SciencesQCL agrees to supply Lobe Sciences research and
newsfileFeb 21, 2023 08:31 ET
Lobe Sciences Ltd (LOBEF) Increases Its Portfolio With Several New Chemical Entities (NCEs)
AB Digital, Inc.Jan 19, 2023 06:10 ET
Lobe Sciences Ltd. Announces Regulatory and Clinical Development Plans For 2022 and Early 2023
Vancouver, British Columbia--(Newsfile Corp. - July 7, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBED) ("Lobe" or the "Company"), a Canadian Biotechnology company committed to discovering and de
newsfileJul 7, 2022 10:30 ET
Lobe Sciences Ltd. and Clearway Global LLC Enter into a Development Agreement to Manage Lobe Sciences Ltd.'s Global Regulatory and Development Strategy and its Implementation
Vancouver, British Columbia--(Newsfile Corp. - June 21, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBED) ("Lobe" or the "Company"), a Canadian Biopsychedelics company committed to discovering and
newsfileJun 21, 2022 09:20 ET
CSE Bulletin: Consolidation - Lobe Sciences Ltd. (LOBE)
Toronto, Ontario--(Newsfile Corp. - Le 9 juin/June 2022) - Lobe Sciences Ltd. (the "Issuer") has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-cons
newsfileJun 9, 2022 15:05 ET
No Data
No Data